MedTrace Logo

Spinal Anesthesia by Hyperbaric Prilocaine in Day-Case Perianal Surgery

NCT06600048 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2025-03-27

No results posted yet for this study

Summary

The aim of this study is to evaluate the effect of spinal anesthesia by hyperbaric prilocaine in day-case perianal surgery.

Conditions

  • Spinal Anesthesia
  • Hyperbaric
  • Prilocaine
  • Day-Case
  • Perianal Surgery

Interventions

DRUG

Hyperbaric prilocaine

Patients will receive 1.5 ml (30 mg) 0.5% hyperbaric prilocaine.

DRUG

Hyperbaric bupivacaine

Patients will receive 1.5 ml (7.5 mg) 0.5% hyperbaric bupivacaine.

Sponsors & Collaborators

  • Tanta University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-17
Primary Completion
2025-03-01
Completion
2025-03-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06600048 on ClinicalTrials.gov